Sio Capital Management, LLC Fulcrum Therapeutics, Inc. Transaction History

Sio Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$7.28 - $30.97 $564,032 - $2.4 Million	-77,477 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.09 - $12.0 $920,601 - $1.37 Million	-113,795 Reduced 59.49%	77,477 $812,000
Q1 2021 May 14, 2021	BUY	$10.94 - $15.32 $492,300 - $689,400	45,000 Added 30.76%	191,272 $2.25 Million
Q4 2020 Feb 16, 2021	BUY	$7.84 - $13.4 $1.15 Million - $1.96 Million	146,272 New	146,272 $1.71 Million

130

51.6M

1.04M

32.6K

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $200M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.